Search research articles
Contact Us
Filters
Showing results (141-150 of 196) with videos related to
Page
of 20
Sort By:
Nature Communications
|
April 15, 2020
Selective inhibition of cancer cell self-renewal through a Quisinostat-histone H1.0 axis
Cristina Morales Torres, Mary Y Wu, Sebastijan Hobor, et al.
Cell Reports
|
May 18, 2016
Multiomic Analysis of the UV-Induced DNA Damage Response
Stefan Boeing, Laura Williamson, Vesela Encheva, et al.
Nature Communications
|
April 20, 2022
USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer
Jessica K Nelson, May Zaw Thin, Theodore Evan, et al.
Nature Communications
|
September 26, 2025
EXO1 as a therapeutic target for Fanconi Anaemia, ZRSR2 and BRCA1-A complex deficient cancers
Marija Maric, Sandra Segura-Bayona, Raviprasad Kuthethur, et al.
Lancet (London, England)
|
January 23, 2022
Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patients
Edward J Carr, Mary Wu, Ruth Harvey, et al.
The Biochemical Journal
|
July 1, 2021
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase
Jingkun Zeng, Florian Weissmann, Agustina P Bertolin, et al.
Cancer Discovery
|
January 11, 2017
APC/C Dysfunction Limits Excessive Cancer Chromosomal Instability
Laurent Sansregret, James O Patterson, Sally Dewhurst, et al.
Cell Reports
|
January 18, 2016
Knockout of the PKN Family of Rho Effector Kinases Reveals a Non-redundant Role for PKN2 in Developmental Mesoderm Expansion
Ivan Quétier, Jacqueline J T Marshall, Bradley Spencer-Dene, et al.
Obesity Surgery
|
June 8, 2006
Open versus laparoscopic Roux-en-Y gastric bypass: a comparative study of over 25,000 open cases and the major laparoscopic bariatric reported series
Kenneth B Jones, Joseph D Afram, Peter N Benotti, et al.
Lancet (London, England)
|
October 9, 2022
WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessed
Mary Y Wu, Edward J Carr, Ruth Harvey, et al.
Page
of 20
Search research articles
Search
Showing results (141-150 of 196) with videos related to
Sort By:
Page
of 20
Nature Communications
|
April 15, 2020
Selective inhibition of cancer cell self-renewal through a Quisinostat-histone H1.0 axis
Cristina Morales Torres, Mary Y Wu, Sebastijan Hobor, et al.
Cell Reports
|
May 18, 2016
Multiomic Analysis of the UV-Induced DNA Damage Response
Stefan Boeing, Laura Williamson, Vesela Encheva, et al.
Nature Communications
|
April 20, 2022
USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer
Jessica K Nelson, May Zaw Thin, Theodore Evan, et al.
Nature Communications
|
September 26, 2025
EXO1 as a therapeutic target for Fanconi Anaemia, ZRSR2 and BRCA1-A complex deficient cancers
Marija Maric, Sandra Segura-Bayona, Raviprasad Kuthethur, et al.
Lancet (London, England)
|
January 23, 2022
Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patients
Edward J Carr, Mary Wu, Ruth Harvey, et al.
The Biochemical Journal
|
July 1, 2021
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase
Jingkun Zeng, Florian Weissmann, Agustina P Bertolin, et al.
Cancer Discovery
|
January 11, 2017
APC/C Dysfunction Limits Excessive Cancer Chromosomal Instability
Laurent Sansregret, James O Patterson, Sally Dewhurst, et al.
Cell Reports
|
January 18, 2016
Knockout of the PKN Family of Rho Effector Kinases Reveals a Non-redundant Role for PKN2 in Developmental Mesoderm Expansion
Ivan Quétier, Jacqueline J T Marshall, Bradley Spencer-Dene, et al.
Obesity Surgery
|
June 8, 2006
Open versus laparoscopic Roux-en-Y gastric bypass: a comparative study of over 25,000 open cases and the major laparoscopic bariatric reported series
Kenneth B Jones, Joseph D Afram, Peter N Benotti, et al.
Lancet (London, England)
|
October 9, 2022
WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessed
Mary Y Wu, Edward J Carr, Ruth Harvey, et al.
Page
of 20